NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE244280 Query DataSets for GSE244280
Status Public on Oct 02, 2023
Title Oncogenic GNAS drives a gastric phenotype in Intraductal Papillary Mucinous Neoplasms of the pancreas
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary Intraductal Papillary Mucinous Neoplasms (IPMNs) of the pancreas are cyst-like precursor lesions that give rise to 25% of pancreatic ductal adenocarcinomas (PDAC). While ~90% of cases are diagnosed before cancer forms, metrics and markers by which to determine if an IPMN will progress are currently lacking. Overall, 96% of IPMNs harbor KRAS (~80%) and/or GNAS (~66%) driver mutations and IPMN may be classified as either gastric, intestinal, or pancreatobiliary type. Recently, we identified a shared program of pyloric type metaplasia between pancreatic and gastric injury. Here, we combined immunostaining, RNA-sequencing, molecular biology, and analysis of patient samples to identify major drivers of this program in IPMN. Methods Single cell RNA-sequencing datasets of human IPMN were assayed for markers of pyloric-type metaplasia. 37 IPMN patient samples were immunostained using MxIHC for MUC5AC, CD44v9, and AQP5. KrasG12D and GnasR201C expression was modified in IPMN cell lines to identify transcriptomic programs driven by each oncogene, and in combination. Gene sets were compared to murine and human gastric cell types. Transcriptomic drivers were identified and manipulated in vitro. Candidate driver expression was evaluated by immunostaining of patient IPMN and graded. Results Analysis of published bulk and scRNA-seq IPMN datasets revealed expression of previously described markers of pyloric type metaplasia. Marker expression was confirmed in patient samples. Manipulation of KrasG12D and GnasR201C expression in IPMN cell lines identified the relative contributions of each oncogene to this gastric phenotype. Regulon analysis suggests that transcription factors SPDEF, CREB3L1, and CREB3L4 amplify this program in response to GnasR201C expression. All transcription factors were expressed in patient IPMN samples. Conclusions In response to oncogenic mutation(s), IPMN form in the pancreas and express markers of pyloric type metaplasia. KrasG12D and GnasR201C expression drive this program through independent and synergistic mechanisms that result in amplified expression of mucins and gastrokines, consistent with the phenotype identified in vivo.
 
Overall design Cell lines with doxycyline-inducible human GNASR201C expression were grown with or without doxycycline and with siRNA targeting Kras, Gnas, both in combination, or control
 
Contributor(s) DelGiorno KE, Tan MB, Ivanov S, Jyotsana N
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Sep 28, 2023
Last update date Oct 11, 2023
Contact name Kathleen E DelGiorno
E-mail(s) kathydelgiorno@gmail.com
Organization name Vanderbilt University
Department Cell and Developmental Biology
Lab DelGiorno
Street address 465 21st Ave S
City Nashville
State/province TN
ZIP/Postal code 37232
Country USA
 
Platforms (1)
GPL24247 Illumina NovaSeq 6000 (Mus musculus)
Samples (48)
GSM7810506 Dox_CTRLsi_1
GSM7810507 Dox_CTRLsi_2
GSM7810508 Dox_CTRLsi_3
Relations
BioProject PRJNA1022058

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE244280_10007_normalized_counts.csv.gz 3.5 Mb (ftp)(http) CSV
GSE244280_10007_raw_counts.csv.gz 1.1 Mb (ftp)(http) CSV
GSE244280_9522_normalized_counts.csv.gz 3.0 Mb (ftp)(http) CSV
GSE244280_9522_raw_counts.csv.gz 903.4 Kb (ftp)(http) CSV
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap